Volume 20, Issue 1 (January 2022)                   IJRM 2022, 20(1): 1-12 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini S E, Ilkhani M, Rohani C, Nikbakht Nasrabadi A, Ghanei Gheshlagh R, Moini A. Prevalence of sexual dysfunction in women with cancer: A systematic review and meta-analysis. IJRM 2022; 20 (1) :1-12
URL: http://ijrm.ir/article-1-2074-en.html
Prevalence of sexual dysfunction in women with cancer: A systematic review and meta-analysis
Seyedeh Esmat Hosseini1 , Mahnaz Ilkhani * 2, Camelia Rohani3 , Alireza Nikbakht Nasrabadi4 , Raza Ghanei Gheshlagh5 , Ashraf Moini6
1- Department of Medical Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Medical Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Cancer Research Center, Shahid Beheshati University of Medical Sciences, Tehran, Iran. , m_ilkhani@yahoo.com
3- Department of Health Care Sciences, Palliative Care Center, Ersta Sköndal Bräcke University College, Campus Ersta, Stockholm, Sweden. Department of Community Health Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4- School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
5- Spiritual Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
6- Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran. Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Department of Obstetrics and Gynecology, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:   (1377 Views)
Background: Cancer is one of the most common diseases and it has many physical and psychological consequences. Women with cancer are more likely to suffer from sexual dysfunction (SD) than healthy women.
Objective: To estimate the overall prevalence of SD in women with cancer.
Materials and Methods: The international databases Google Scholar, Embase, PubMed, Web of Science, and Scopus were searched for related articles without any time limitation. The keywords “Neoplasia”, “Tumor”, “Cancer”, “Malignancy”, “Female Sexual Function Index”, “FSFI”, and “female sexual dysfunction” along with their combinations were used in the search. Inconsistencies in the data were examined using the I2 test. The data were analyzed using the meta-analysis method and the random-effects model in the Stata software.
Results: The analysis of 24 articles with a sample size of 5483 women showed that the prevalence of SD in women with cancer was 66% (95% CI: 59-74%). The highest and lowest prevalence were in Africa and Europe, respectively (75%; 95% CI: 66-83% vs. 43%; 95% CI: 26-60%, respectively). There was no relationship between the prevalence of SD and the mean age of the women, sample size, year of publication, or quality of articles.
Conclusion: SD is highly prevalent in women with cancer. African and American women with cancer have a higher average FSD prevalence than Asian and European ones.
Keywords: Sexual dysfunction, Prevalence, Meta-analysis, Women, Sex.
Full-Text [PDF 1996 kb]   (1017 Downloads) |   |   Full-Text (HTML)  (346 Views)  
Type of Study: Review Article | Subject: Reproductive Oncology
References
1. Agboola SO, Ju W, Elfiky A, Kvedar JC, Jethwani K. The effect of technology-based interventions on pain, depression, and quality of life in patients with cancer: A systematic review of randomized controlled trials. J Med Internet Res 2015; 17: e65. [DOI:10.2196/jmir.4009] [PMID] [PMCID]
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. [DOI:10.3322/caac.21492] [PMID]
3. Maiorino M, Bellastella G, Giugliano D, Esposito K. From inflammation to sexual dysfunctions: A journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest 2018; 41: 1249-1258. [DOI:10.1007/s40618-018-0872-6] [PMID]
4. Jemal A, Ward EM, Johnson ChJ, Cronin KA, Ma J, Ryerson B, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst 2017; 109: djx030. [DOI:10.1093/jnci/djx030]
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30. [DOI:10.3322/caac.21332] [PMID]
6. American Psychiatric Association. Association, AP Diagnostic and statistical manual of mental disorders. Arlington, USA: American Psychiatric Pub; 2013. [DOI:10.1176/appi.books.9780890425596]
7. Alicikus ZA, Gorken IB, Sen RC, Kentli S, Kinay M, Alanyali H, et al. Psychosexual and body image aspects of quality of life in Turkish breast cancer patients: A comparison of breast conserving treatment and mastectomy. Tumori 2009; 95: 212-218. [DOI:10.1177/030089160909500213] [PMID]
8. Frieben RW, Lin HCh, Hinh PP, Berardinelli F, Canfield SE, Wang R. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: A systematic review. Asian J Androl 2010; 12: 500-508. [DOI:10.1038/aja.2010.33] [PMID] [PMCID]
9. Avis NE, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psychooncology 2004; 13: 295-308. [DOI:10.1002/pon.744] [PMID]
10. Frimer M, Turker LB, Shankar V, Cardaci R, Van Arsdale AR, Rosenthal E, et al. The association of sexual dysfunction with race in women with gynecologic malignancies. Gynecol Oncol Rep 2019; 30: 100495. [DOI:10.1016/j.gore.2019.100495] [PMID] [PMCID]
11. Jeffery DD, Tzeng JP, Keefe FJ, Porter LS, Hahn EA, Flynn KE, et al. Initial report of the cancer patient‐reported outcomes measurement information system (PROMIS) sexual function committee: Review of sexual function measures and domains used in oncology. Cancer 2009; 115: 1142-1153. [DOI:10.1002/cncr.24134] [PMID] [PMCID]
12. Rosen RC, Bachmann GA. Sexual well-being, happiness, and satisfaction, in women: The case for a new conceptual paradigm. J Sex Marital Ther 2008; 34: 291-297. [DOI:10.1080/00926230802096234] [PMID]
13. Stabile C, Gunn A, Sonoda Y, Carter J. Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer. Transl Androl Urol 2015; 4: 169-185.
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting; meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. [DOI:10.1001/jama.283.15.2008] [PMID]
15. Faten E, Nader M, Raies H, Sana M, Amel M, Fadhel M. [Body image disorder in 100 Tunisian female breast cancer patients]. Bull Cancer 2018; 105: 350-356. (in French) [DOI:10.1016/j.bulcan.2018.01.008] [PMID]
16. Robinson PJ, Bell RJ, Christakis MK, Ivezic SR, Davis SR. Aromatase inhibitors are associated with low sexual desire causing distress and fecal incontinence in women: An observational study. J Sex Med 2017; 14: 1566-1574. [DOI:10.1016/j.jsxm.2017.09.018] [PMID]
17. Gass JS, Onstad M, Pesek S, Rojas K, Fogarty S, Stuckey A, et al. Breast-specific sensuality and sexual function in cancer survivorship: Does surgical modality matter? Ann Surg Oncol 2017; 24: 3133-3140. [DOI:10.1245/s10434-017-5905-4] [PMID]
18. Paiva CE, Rezende FF, Paiva BSR, Mauad EC, Zucca-Matthes G, Carneseca EC, et al. Associations of body mass index and physical activity with sexual dysfunction in breast cancer survivors. Arch Sex Behav 2016; 45: 2057-2068. [DOI:10.1007/s10508-016-0758-7] [PMID]
19. Boquiren VM, Esplen MJ, Wong J, Toner B, Warner E, Malik N. Sexual functioning in breast cancer survivors experiencing body image disturbance. Psychooncology 2016; 25: 66-76. [DOI:10.1002/pon.3819] [PMID]
20. Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC. Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health 2014; 29: 632-650. [DOI:10.1080/08870446.2013.879136] [PMID] [PMCID]
21. Schover LR, Baum GP, Fuson LA, Brewster A, Melhem‐Bertrandt A. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med 2014; 11: 3102-3111. [DOI:10.1111/jsm.12684] [PMID] [PMCID]
22. Safarinejad MR, Shafiei N, Safarinejad S. Quality of life and sexual functioning in young women with early‐stage breast cancer 1 year after lumpectomy. Psychooncology 2013; 22: 1242-1248. [DOI:10.1002/pon.3130] [PMID]
23. Pumo V, Milone G, Iacono M, Giuliano SR, Di Mari A, Lopiano C, et al. Psychological and sexual disorders in long-term breast cancer survivors. Cancer Manag Res 2012; 4: 61-65. [DOI:10.2147/CMAR.S28547] [PMID] [PMCID]
24. Harirchi I, Montazeri A, Bidokhti FZ, Mamishi N, Zendehdel K. Sexual function in breast cancer patients: A prospective study from Iran. J Exp Clin Cancer Res 2012; 31: 20. [DOI:10.1186/1756-9966-31-20] [PMID] [PMCID]
25. Boehmer U, Ozonoff A, Timm A, Winter M, Potter J. After breast cancer: Sexual functioning of sexual minority survivors. J Sex Res 2014; 51: 681-689. [DOI:10.1080/00224499.2013.772087] [PMID]
26. Reese JB, Handorf E, Haythornthwaite JA. Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: A longitudinal study. Support Care Cancer 2018; 26: 3431-3440. [DOI:10.1007/s00520-018-4204-3] [PMID] [PMCID]
27. He H, Yang Z, Zeng D, Yao D, Fan J, Zhao R, et al. [Comparison of the short-term and long-term outcomes of laparoscopic surgery and open surgery for early-stage cervical cancer]. Zhonghua Zhong Liu Za Zhi 2017; 39: 458-466. (in Chinese)
28. Tsai TY, Chen SY, Tsai MH, Su YL, Ho CM, Su HF. Prevalence and associated factors of sexual dysfunction in cervical cancer patients. J Sex Med 2011; 8: 1789-1796. [DOI:10.1111/j.1743-6109.2010.01745.x] [PMID]
29. Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, et al. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol 2010; 119: 358-365. [DOI:10.1016/j.ygyno.2010.07.016] [PMID] [PMCID]
30. Damast Sh, Alektiar K, Eaton A, Gerber NK, Goldfarb S, Patil S, et al. Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer. Ann Surg Oncol 2014; 21: 2740-2754. [DOI:10.1245/s10434-014-3562-4] [PMID]
31. Damast Sh, Alektiar KM, Goldfarb S, Eaton A, Patil S, Mosenkis J, et al. Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy. Int J Radiat Oncol Biol Phys 2012; 84: e187-e193. [DOI:10.1016/j.ijrobp.2012.03.030] [PMID] [PMCID]
32. Onujiogu N, Johnson T, Seo S, Mijal K, Rash J, Seaborne L, et al. Survivors of endometrial cancer: Who is at risk for sexual dysfunction? Gynecol Oncol 2011; 123: 356-359. [DOI:10.1016/j.ygyno.2011.07.035] [PMID]
33. Chan JL, Senapati S, Johnson LNC, DiGiovanni L, Voong Ch, Butts SF, et al. Risk factors for sexual dysfunction in BRCA mutation carriers following risk-reducing salpingo-oophorectomy. Menopause 2019; 26: 132-139. [DOI:10.1097/GME.0000000000001176] [PMID] [PMCID]
34. Segelman J, Martling A, Machado M, Holm T, Bergmark K, Rådestad AF. Preoperative sexual function in women with rectal cancer. Eur J Surg Oncol 2013; 39: 1079-1086. [DOI:10.1016/j.ejso.2013.07.091] [PMID]
35. Moroney MR, Flink D, Sheeder J, Blake EA, Carrubba AR, Fisher CM, et al. Radiation therapy is not an independent risk factor for decreased sexual function in women with gynecologic cancers. Rep Pract Oncol Radiother 2018; 23: 331-336. [DOI:10.1016/j.rpor.2018.07.007] [PMID] [PMCID]
36. Carter J, Stabile C, Seidel B, Baser RE, Gunn AR, Chi S, et al. Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a female sexual medicine program. Support Care Cancer 2015; 23: 2255-2265. [DOI:10.1007/s00520-014-2573-9] [PMID] [PMCID]
37. Maiorino MI, Chiodini P, Bellastella G, Giugliano D, Esposito K. Sexual dysfunction in women with cancer: A systematic review with meta-analysis of studies using the female sexual function index. Endocrine 2016; 54: 329-341. [DOI:10.1007/s12020-015-0812-6] [PMID]
38. Schofield Ch, Newton RU, Cohen PA, Galvão DA, McVeigh JA, Mohan GR, et al. Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics. Support Care Cancer 2018; 26: 2239-2246. [DOI:10.1007/s00520-018-4069-5] [PMID]
39. Jing L, Zhang Ch, Li W, Jin F, Wang A. Incidence and severity of sexual dysfunction among women with breast cancer: A meta-analysis based on female sexual function index. Support Care Cancer 2019; 27: 1171-1180. [DOI:10.1007/s00520-019-04667-7] [PMID]
40. Falk SJ, Dizon DS. Sexual dysfunction in women with cancer. Fertil Steril 2013; 100: 916-921. [DOI:10.1016/j.fertnstert.2013.08.018] [PMID]
41. Laumann Eo, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537-544. [DOI:10.1001/jama.281.6.537] [PMID]
42. Irandoost S, Nasiri A, Izadpanahi P. [Evaluation of sexual function and its related factors in females with breast cancer undergoing chemotherapy in Iran-Mehr medical center, Birjand, Iran, 2018]. J Birjand Univ Med Sci 2020; 27: 366-375. (in Persian)
43. Andersen BL. Yes, there are sexual problems. Now, what can we do about them? Gynecol Oncol 1994; 52: 10-13. [DOI:10.1006/gyno.1994.1003] [PMID]
44. Lindau ST, Gavrilova N, Anderson D. Sexual morbidity in very long term survivors of vaginal and cervical cancer: A comparison to national norms. Gynecol Oncol 2007; 106: 413-418. [DOI:10.1016/j.ygyno.2007.05.017] [PMID] [PMCID]
45. Carter J, Stabile C, Gunn A, Sonoda Y. The physical consequences of gynecologic cancer surgery and their impact on sexual, emotional, and quality of life issues. J Sex Med 2013; 10 (Suppl.): 21-34. [DOI:10.1111/jsm.12002] [PMID]
46. Hopkins TG, Stavraka C, Gabra H, Fallowfield L, Hood C, Blagden S. Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation. Climacteric 2015; 18: 94-98. [DOI:10.3109/13697137.2014.929104] [PMID]
47. Harding Y, Ooyama T, Nakamoto T, Wakayama A, Kudaka W, Inamine M, et al. Radiotherapy-or radical surgery-induced female sexual morbidity in stages IB and II cervical cancer. Int J Gynecol Cancer 2014; 24: 800-805. [DOI:10.1097/IGC.0000000000000112] [PMID]
48. Sertoz OO, Mete HE, Noyan A, Alper M, Kapkaç M. [Effects of surgery type on body image, sexuality, self-esteem, and marital adjustment in breast cancer: A controlled study]. Turk Psikiyatri Derg 2004; 15: 264-275. (in Turkish)
49. Fredrickson BL, Roberts TA. Objectification theory: Toward understanding women's lived experiences and mental health risks. Psychol Women Quarter 1997; 21: 173-206. [DOI:10.1111/j.1471-6402.1997.tb00108.x]
50. Holzner B, Kemmler G, Kopp M, Moschen R, Schweigkofler HR, Du Nser M, et al. Quality of life in breast cancer patients-not enough attention for long-term survivors? Psychosomatics 2001; 42: 117-123. [DOI:10.1176/appi.psy.42.2.117] [PMID]
51. Hannoun-Levi J. [Treatment of breast and uterus cancer: Physiological and psychological impact on sexual function]. Cancer Radiother 2005; 9: 175-182. (in French) [DOI:10.1016/j.canrad.2004.11.005] [PMID]
52. Angelopoulos N, Barbounis V, Livadas S, Kaltsas D, Tolis G. Effects of estrogen deprivation due to breast cancer treatment. Endocr Relat Cancer 2004; 11: 523-535. [DOI:10.1677/erc.1.00783] [PMID]
53. Lewis RW. A critical look at descriptive epidemiology of sexual dysfunction in Asia compared to the rest of the world-a call for evidence-based data. Transl Androl Urol 2013; 2: 54-60.
54. Hosseini SE, Ilkhani M, Rohani C, Nikbakht Nasrabadi A. Sexual experience of Iranian women with cancer: A qualitative content analysis. Middle East J Cancer 2021; in Press.
55. WHO. World health statistics 2015. Geneva (Switzerland): World Health Organization; 2015. in Press.
56. Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, et al. Survivorship: Aexual dysfunction (female), version 1.2013. J Natl Compr Canc Netw 2014; 12: 184-192. [DOI:10.6004/jnccn.2014.0019] [PMID] [PMCID]
57. Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, et al. Sexual dysfunction in middle-aged women: A multicenter Latin American study using the female sexual function index. Menopause 2009; 16: 1139-1148. [DOI:10.1097/gme.0b013e3181a4e317] [PMID]
58. Maiorino MI, Bellastella G, Esposito K. Sexual activity in midlife women and beyond. JAMA Intern Med 2014; 174: 1203-1204. [DOI:10.1001/jamainternmed.2014.1621] [PMID]
59. Jensen PT, Klee MC, Thranov I, Groenvold M. Validation of a questionnaire for self‐assessment of sexual function and vaginal changes after gynaecological cancer. Psychooncology 2004; 13: 577-592. [DOI:10.1002/pon.757] [PMID]
60. Bransfield DD, Horiot JC, Nabid A. Development of a scale for assessing sexual function after treatment for gynecologic cancer. J Psychosoc Oncol 1984; 2: 3-19. [DOI:10.1300/J077v02n01_02]
61. Derogatis LR. The Derogatis interview for sexual functioning (DISF/DISF-SR): An introductory report. J Sex Marital Ther 1997; 23: 291-304. [DOI:10.1080/00926239708403933] [PMID]
62. Clayton AH, McGarvey EL, Clavet G. The changes in sexual functioning guestlonnaire (CSFO): Development, reliability, and validity. Psychopharmacol Bull 1997; 33: 731-745.
63. Press P. European organization for research on treatment of cancer (eortc) eortc symposium on treatment of neoplastic lesions of the nervous system. Available at: https://www.eortc.org.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb